accessnewswire.com · 2 jul

Gartner(R) Ranks HawkSearch #1 for B2B Search Use Case in 2026 Critical Capabilities Report for Second Consecutive Year

WOBURN, MA / ACCESS Newswire / July 2, 2026 / Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered product discovery and eCommerce solutions, today announced that its HawkSearch platform has been ranked #1 in the B2B Search use case in the Critical Capabilities for Search and Product Discovery 2026 report. This marks the second consecutive year HawkSearch has achieved the highest ranking.

accessnewswire.com · 2 jul

Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion System

~ Updated clearance incorporates various instrument upgrades, as well as per-procedure costs, improving unit economics driven by the reclassification of certain instruments from disposable to reusable status ~ ~ Clearance reflects Tenon's commitment to continuous innovation and operational efficiency, with reusable instrumentation expected to drive lower capex and logistical spend, contributing positively to gross margins and cash flow ~ LOS GATOS, CA / ACCESS Newswire / July 2, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Catamaran® SI Joint Fusion System. The updated clearance incorporates various instrument upgrades, as well as the reclassification of certain instruments from disposable to reusable status.

accessnewswire.com · 1 jul

374Water Added to Russell Microcap(R) Index as It Establishes it Waste Destruction Services Hub

Expanded Visibility Among Institutional Investors Expected to Reflect Growing Value for Customers and Shareholders MORRISVILLE, NC / ACCESS Newswire / July 1, 2026 / 374Water Inc. (NASDAQ:SCWO) ("374Water" or the "Company"), a leading cleantech and environmental services company deploying supercritical water oxidation technology for the permanent destruction of organic waste through its proprietary AirSCWO™, today announced that it has been added to the Russell Microcap® Index following the annual Russell U.S. Indexes reconstitution, effective after the close of U.S. markets on June 26, 2026. "We are excited to be included in the Russell Microcap Index," said Danny Bogar, Chief Executive Officer of 374Water.

newsfilecorp.com · 30 jun

Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus

Toronto, Ontario--(Newsfile Corp. - June 30, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, is pleased to announce that it has filed and obtained a receipt for a final base shelf prospectus dated June 29, 2026 ("Prospectus") with the securities regulatory authorities in all provinces and territories of Canada. The Prospectus will allow Theralase® to offer up to C$100 Million of common shares, warrants, subscription receipts, debt securities or any combination thereof (collectively, the "Securities"), over a 25-month period.

accessnewswire.com · 30 jun

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Microdacyn® Wound Irrigation Solution, including expanded claims, clearance for multiple use, and additional packaging configurations. Under this new clearance, Microdacyn Wound Irrigation Solution can be used under the supervision of a healthcare professional for cleansing, irrigating, moistening, debridement and removal of foreign material including microorganisms from exudating and/or dirty wounds, acute and chronic dermal lesions, such as Stage I-IV pressure ulcers, stasis ulcers, diabetic ulcers, post‑surgical wounds, first and partial thickness second degree burns, abrasions, minor irritations of the skin, diabetic foot ulcers, ingrown toe nails, grafted and donor sites, and exit sites, and for moistening and lubricating absorbent wound dressings.

gurufocus.com · 30 jun

SharkNinja Launches the Shark® PowerDetect® Transformer™: Three Vacuums. One System. Zero Compromises.

SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced the launch of the Shark PowerDetect Transformer™, the best o

accessnewswire.com · 29 jun

FatPipe, Inc. Continues Membership in Russell Microcap(R) Index

SALT LAKE CITY, UT / ACCESS Newswire / June 29, 2026 / FatPipe, Inc. (NASDAQ:FATN) ("FatPipe" or the "Company"), a pioneer and multiple patents holder in enterprise-class software-defined wide area networking (SD-WAN) and single-stack cybersecurity solutions, today announced that it qualified to continue as a member of the Russell Microcap® Index following the June 2026 Russell indexes semi-annual reconstitution, effective when the U.S. market opens on June 29. The June reconstitution of the Russell U.S. indexes captures up to the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization.

accessnewswire.com · 29 jun

NextTrip Added to Russell Microcap(R) Index

SANTA FE, NM / ACCESS Newswire / June 29, 2026 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "the Company," "we," "our," or "us"), a technology-forward travel and media company defining the intersection of media and travel, today announced that it will be added as a member of the Russell Microcap® Index, effective when the U.S. market opened on June 29, 2026, as part of the 2026 Russell indexes reconstitution. The annual Russell US Indexes reconstitution captures the 4,000 largest U.S. stocks as of April 30, ranked by total market capitalization.